GlassScriptPhysician profile
John C Hwang
NPI 1629235510
$3,578.94
in general payments reported to CMS, 2019-2025
17 companies · $58.39 in 2025
The $58.39 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $1,619 · 2021: $163 · 2022: $682 · 2023: $285 · 2024: $295 · 2025: $58.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.71 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 108 LLC | $1,575.00 | 2020 | |
| Genentech USA, INC. | $629.21 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $257.31 | 2019-2023 | Eylea Hd, Eylea |
| Cardinal Health 110 LLC | $150.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $141.03 | 2019 | |
| Alcon Vision LLC | $135.08 | 2019 | |
| New World Medical,INC. | $124.18 | 2019 | |
| Eyepoint US, INC. | $117.44 | 2022 | |
| Genentech, INC. | $114.89 | 2024 | Vabysmo |
| Alimera Sciences, INC. | $111.13 | 2022 | |
| Astellas Pharma US INC | $85.43 | 2023-2025 | Izervay |
| Abbvie INC. | $40.87 | 2023-2025 | |
| Optos, INC. | $27.72 | 2019 | |
| Apellis Pharmaceuticals, INC. | $21.76 | 2023 | Syfovre |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.61 | 2023 | Taltz |
| Amgen INC. | $13.88 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.